Sci-Tech News Today
SEE OTHER BRANDS

The latest news on science and technology

Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on September 5, 2025

AKT Health Announces Hakase AI to Transform Life Sciences with a Comprehensive AI Platform

AKT Health Announces Hakase AI to Transform Life Sciences with a Comprehensive AI Platform

Hakase AI unites Clinical, Commercial …

The Race to Out-Innovate Threats from a ‘Smarter’ Enemy – Roke's story

The Race to Out-Innovate Threats from a ‘Smarter’ Enemy – Roke's story

HAMPSHIRE, UNITED KINGDOM, September 5, 2025 /⁨EINPresswire.com⁩/ -- The modern battlespace has evolved dramatically, driven by real-world developments such as hybrid warfare in Ukraine - including sophisticated cyber and electromagnetic attacks on …

Global Leaders to Explore AI, Health Equity & Digital Innovation at Healthark’s RWEsearch & Health Innovation Summit

Global Leaders to Explore AI, Health Equity & Digital Innovation at Healthark’s RWEsearch & Health Innovation Summit

55+ experts, 20+ sessions: RWEsearch …

Satoyama Mace Initiative Launches Bio-Integrated Breakthrough for Sustainable Hydrogen and Carbon Equity

Satoyama Mace Initiative Launches Bio-Integrated Breakthrough for Sustainable Hydrogen and Carbon Equity

Bio-inspired Chlorophyll/Cu₂O electrode boosts hydrogen efficiency and durability, linking clean energy innovation with SEPLS carbon credit equity. TAIPEI, TAIWAN, September 5, 2025 /⁨EINPresswire.com⁩/ -- The Satoyama Mace Initiative today announced a …

AI Can Evaluate Social Situations Similar to Humans

AI Can Evaluate Social Situations Similar to Humans

Artificial intelligence can detect and interpret social features between people from images and videos almost as reliably as humans. TURKU, FINLAND, September 5, 2025 /⁨EINPresswire.com⁩/ -- Artificial intelligence can detect and interpret social features …

Daram Showcases Enhanced Kaisar Men’s Healthcare Device at IFA 2025 – Second Consecutive Year of Global Presence

Daram Showcases Enhanced Kaisar Men’s Healthcare Device at IFA 2025 – Second Consecutive Year of Global Presence

SEOUL, SEOUL, SOUTH KOREA, September 4, 2025 /⁨EINPresswire.com⁩/ -- Daram Co., Ltd., a South Korean healthcare technology innovator, is proud to announce its participation in IFA 2025, marking its third consecutive year at the world’s leading consumer …

DVDFab at 23: A Year of Feature and Performance Upgrades

DVDFab at 23: A Year of Feature and Performance Upgrades

Marking 23 years, DVDFab has grown from a focused 2003 DVD tool into a comprehensive suite trusted by creators, collectors, educators, and home‑cinema fans. CA, UNITED STATES, September 4, 2025 /⁨EINPresswire.com⁩/ -- Three pillars of DVDFab have stayed …

Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future

Blocksize Exposes Hidden Custodial Staking Risks, Calls for Transparency and Governance to Secure Solana’s Future

Frankfurt, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Blocksize, a German-based DeFi infrastructure provider, is calling attention to the hidden fees of custodial staking platforms, which quietly erode yields, undermine governance, and place long-term …

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

Theratechnologies Announces Availability of EGRIFTA WR™ (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy

EGRIFTA WR™ offers convenience of weekly reconstitution and reduced daily injection volume, compared to EGRIFTA SV® Specialty pharmacies are now ordering EGRIFTA WR™ to fill prescriptions MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. …

NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board

NextGen Digital Platforms Inc. Appoints Mark Creaser to Advisory Board

Vancouver, B.C. , Sept. 05, 2025 (GLOBE NEWSWIRE) -- NextGen Digital Platforms Inc. (CSE:NXT) (OTCQB:NXTDF) (FSE:Z12) (“NextGen” or the “Company”) a digital asset and fintech platform bridging traditional capital markets with Web3 infrastructure, is …

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that on …

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

iBio Reports Fiscal Year 2025 Financial Results and Provides Corporate Update

SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced its financial results for the fiscal year ended June 30, 2025, and provided a corporate update on its progress. …

Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie

Theratechnologies annonce la disponibilité d’EGRIFTA WR (MC) (tésamoréline) pour injection pour la réduction de l’excès de graisse abdominale chez les adultes vivant avec le VIH atteints de lipodystrophie

EGRIFTA WRMC offre la commodité d’une reconstitution hebdomadaire et d’un volume d’injection quotidien réduit, comparativement à EGRIFTA SVMD Les pharmacies spécialisées commandent désormais EGRIFTA WRMC pour exécuter les ordonnances MONTRÉAL, 05 sept. …

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

uniQure Announces Initial AMT-191 Phase I/IIa Data Showing Sustained Increases in α-Gal A Enzyme Activity in Patients with Fabry Disease

~ All patients in the first cohort achieved between 27- to 208-fold increases in α-Gal A activity relative to mean normal level ~ ~ All patients in first cohort discontinued enzyme replacement therapy ~ ~ Preliminary data show AMT-191 has a manageable …

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program

-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on …

Aldebaran Announces Intention to Spin Out Northern Argentina Exploration Projects into a New Argentine-Focused Exploration Company and Provides an Update on the Altar PEA

Aldebaran Announces Intention to Spin Out Northern Argentina Exploration Projects into a New Argentine-Focused Exploration Company and Provides an Update on the Altar PEA

VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to announce its intention to transfer its portfolio of projects located in Salta, Jujuy, and …

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

- Robust 24-month complete response (CR) rate of 41.8% observed for cretostimogene monotherapy in patients with high-risk non-muscle invasive bladder cancer (NMIBC) who are unresponsive to Bacillus Calmette Guerin (BCG) treatment - - 90% of 12-month …

Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

Medicenna to Participate at the H.C. Wainwright 27th Annual Global Investment Conference

TORONTO and HOUSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr. …

Tecnoglass Increases Availability under Revolving Credit Facility and Extends Maturity Date to 2030

Tecnoglass Increases Availability under Revolving Credit Facility and Extends Maturity Date to 2030

- Facility Increases to $500 million from $150mm, Providing Signficant Financial Flexibility for Growth and Capital Allocation - - Reduces All-In Borrowing Costs by 25 Basis Points Across All Pricing Tiers While Extending Maturity to 2030 - - Net Debt to …

Koryx Copper Announces Planned Continuation to Luxembourg

Koryx Copper Announces Planned Continuation to Luxembourg

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Koryx Copper Inc. (the “Company”) (TSX-V: KRY) (NSX: KYX) today announced its intention to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions